Angiodynamic OverviewAngiodynamic EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ANGO.
Quarterly EBIT
-$3.76M
↑ 43.43% YoY
As of Feb 28, 2026
Annual EBIT (TTM)
-$14.64M
↑ 52.18% YoY
Trailing 12 months ending Feb 28, 2026
Angiodynamic OverviewEBIT (Earnings Before Interest and Taxes) analysis for ANGO.
As of Feb 28, 2026
Trailing 12 months ending Feb 28, 2026